Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases

Kidney International

Volumn 70, Issue 7, 2006, Pages 1332-1341

  Di Duca, M ^a   Oleggini, R ^a   Sanna Cherchi, S ^b   Pasquali, L ^a   Di Donato, A ^a   Parodi, S ^a   Bertelli, R ^a   Caridi, G ^a   Frasca, G ^c   Cerullo, G ^d   Amoroso, A ^e   Schena, F P ^d   Scolari, F ^f   Ghiggeri, G M ^a  

^a G GASLINI INSTITUTE   (Italy)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Focal segmental glomerulosclerosis; Haplotype analysis; IgA; Nephropathy; Podocin expression; Progression of renal diseases; Trans acting elements

Indexed keywords

CIS ACTING ELEMENT; CREATININE; PODOCIN; TRANS ACTING FACTOR; UPSTREAM STIMULATORY FACTOR 1;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FOCAL GLOMERULOSCLEROSIS; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION PROFILING; GENE LINKAGE DISEQUILIBRIUM; GENE SILENCING; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NONHUMAN; NPHS2 GENE; OUTCOME ASSESSMENT; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEINURIA; REPORTER GENE; RNA INTERFERENCE; WILD TYPE;

ADOLESCENT; ADULT; AGED; ANIMALS; CELL LINE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; CREATININE; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC VARIATION; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HAPLOTYPES; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; LUCIFERASES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEPHROTIC SYNDROME; PODOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEINURIA; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VARIATION (GENETICS);

EID: 33748922778     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001767     Document Type: Article

References (37)

1. Braden GL, Mulhern JG, O'Shea MH et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000; 35: 878-883.
2. Bonilla-Felix M, Parra C, Dajani T et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 1999; 55: 1885-1890.
3. Brown DM, Provoost AP, Daly MJ et al. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 1996; 12: 44-51.
4. Zheng F, Striker GE, Esposito C et al. Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 1998; 54: 1999-2007.
5. Lenkkeri U, Mannikko M, McCready P et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999; 64: 51-61.
6. Reiser J, Kriz W, Kretzler M et al. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000; 11: 1-8.
7. Huber TB, Simons M, Hartleben B et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 2003; 12: 3397-3405.
8. Kim JM, Wu H, Green G et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298-1300.
9. Dusel JA, Burdon KP, Hicks PJ et al. Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 2005; 68: 256-262.
10. Roselli S, Heidet L, Sich M et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004; 24: 550-560.
11. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-354.
12. Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003; 41: 1314-1321.
13. Caridi G, Perfumo F, Ghiggeri GM. NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 2005; 57: 54R-61R.
14. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071.
15. Guan N, Ding J, Zhang J et al. Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol 2003; 18: 1122-1127.
16. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966.
17. Nishibori Y, Liu L, Hosoyamada M et al. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int 2004; 66: 1755-1765.
18. Moeller MJ, Sanden SK, Soofi A et al. Two gene fragments that direct podocyte-specific expression in transgenic mice. J Am Soc Nephrol 2002; 13: 1561-1567.
19. Moeller MJ, Sanden SK, Soofi A et al. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35: 39-42.
20. Oleggini R, Bertelli R, Di Donato A et al. Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome. Gene Expr 2006; 13: 59-66.
21. Schena FP, Cerullo G, Torres DD et al. The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait. BMC Nephrol 2005; 6: 14.
22. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
23. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
24. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
25. Doublier S, Ruotsalainen V, Salvidio G et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158: 1723-1731.
26. Doublier S, Salvidio G, Lupia E et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-1030.
27. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196.
28. Eardley KS, Ferreira MA, Howie AJ et al. Urinary albumin excretion: a predictor of glomerular findings in adults with microscopic haematuria. Quart J Med 2004; 97: 297-301.
29. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol 2004; 24: 218-224.
30. Kanno Y, Okada H, Yamaji Y et al. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. Quart J Med 2005; 98: 199-203.
31. ISKDC. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of kidney disease in children. Lancet 1974; 2: 423-427.
32. ISKDC. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International study of kidney disease in children. Kidney Int 1981; 20: 765-771.
33. Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994; 23: 773-783.
34. Billing H, Muller D, Ruf R et al. NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr Nephrol 2004; 19: 561-564.
35. Karle SM, Uetz B, Ronner V et al. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002; 13: 388-393.
36. Giampuzzi M, Botti G, Di Duca M et al. Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem 2000; 275: 36341-36349.
37. Gabriel SB, Salomon R, Pelet A et al. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet 2002; 31: 89-93.